7-[[2-chloro-6-fluoro-3-(6-piperazin-1-yl-3-pyridinyl)phenyl]methoxy]-2H-triazolo[4,5-b]pyridin-5-amine
C21H20ClFN8O — CID 126680454
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[[2-chloro-6-fluoro-3-(6-piperazin-1-yl-3-pyridinyl)phenyl]methoxy]-2H-triazolo[4,5-b]pyridin-5-amine
7-[[2-chloro-6-fluoro-3-(6-piperazin-1-yl-3-pyridinyl)phenyl]methoxy]-2H-triazolo[4,5-b]pyridin-5-amine (PubChem CID 126680454) has the molecular formula C21H20ClFN8O and a molecular weight of 454.90 g/mol. Its IUPAC name is 7-[[2-chloro-6-fluoro-3-(6-piperazin-1-yl-3-pyridinyl)phenyl]methoxy]-2H-triazolo[4,5-b]pyridin-5-amine.
Molecular Properties
| Compound Name | 7-[[2-chloro-6-fluoro-3-(6-piperazin-1-yl-3-pyridinyl)phenyl]methoxy]-2H-triazolo[4,5-b]pyridin-5-amine |
|---|---|
| PubChem CID | 126680454 |
| Molecular Formula | C21H20ClFN8O |
| Molecular Weight | 454.90 g/mol |
| Exact Mass | 454.14 |
| IUPAC Name | 7-[[2-chloro-6-fluoro-3-(6-piperazin-1-yl-3-pyridinyl)phenyl]methoxy]-2H-triazolo[4,5-b]pyridin-5-amine |
| SMILES | Nc1cc(OCc2c(F)ccc(-c3ccc(N4CCNCC4)nc3)c2Cl)c2n[nH]nc2n1 |
| InChI | InChI=1S/C21H20ClFN8O/c22-19-13(12-1-4-18(26-10-12)31-7-5-25-6-8-31)2-3-15(23)14(19)11-32-16-9-17(24)27-21-20(16)28-30-29-21/h1-4,9-10,25H,5-8,11H2,(H3,24,27,28,29,30) |
| InChIKey | OJYVIRMRIJPFHR-UHFFFAOYSA-N |
| XLogP | 2.78 |
| TPSA | 117.87 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 454.90 |
| LogP ≤ 5 | 2.78 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126680454 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.